登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《MedRixv，3月3日，Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-04

  • Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

    Li Tan, Qi Wang, Duanyang Zhang, Jinya Ding, Qianchuan Huang, Yi-Quan Tang, Qiongshu Wang, Hongming Miao

    doi: https://doi.org/10.1101/2020.03.01.20029074

    Abstract

    Background: Coronavirus disease-2019 (COVID-19) is a rapidly escalating epidemic caused by SARS-CoV-2. Identification of a simple and effective indicator to assess disease severity and outcome is urgently needed. Methods: This study retrospectively analyzed dynamic changes of lymphocyte percentage (LYM%) in 15 death cases, 15 severe cases as well as 40 moderate cases of COVID-19 patients. Next, prognostic role of lymphopenia in COVID-19 were verified in 92 hospitalized cases.

    *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.

  • 原文来源：https://www.medrxiv.org/content/10.1101/2020.03.01.20029074v1
49浏览量
原文链接
相关报告

  • 《SSRN，3月3日，Early and Critical Care in Severe Patients with COVID-19 in Jiangsu Province, China: A Descriptive Study》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-04
    • Early and Critical Care in Severe Patients with COVID-19 in Jiangsu Province, China: A Descriptive Study 24 Pages Posted: 3 Mar 2020 Mao Huang Nanjing Medical University - Department of Pulmonary and Critical Care Medicine Yi Yang Southeast University (China) - Department of Critical Care Medicine Abstract Background: Patients with coronavirus disease 2019 (COVID-19) infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which originated in Wuhan, China, and spreading over the country including Jiangsu Province. Our study aimed to study the epidemiological, clinical characteristics and therapies of these severe cases in Jiangsu Province.
    160浏览量
    原文链接

  • 《LANCET，3月13日，COVID-19, ECMO, and lymphopenia: a word of caution》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-03-14
    • COVID-19, ECMO, and lymphopenia: a word of caution Brandon Michael Henry Published:March 13, 2020DOI:https://doi.org/10.1016/S2213-2600(20)30119-3 Extracorporeal membrane oxygenation (ECMO) can serve as life-saving rescue therapy for refractory respiratory failure in the setting of acute respiratory distress syndrome, such as that induced by coronavirus disease 2019 (COVID-19). In the study by Yang and colleagues,1 who compared clinical characteristics and outcomes in patients with severe COVID-19, five (83%) of six patients receiving ECMO died. Although this sample was small, and specific baseline characteristics and disease courses were almost unknown, it raises concerns about potential harms of ECMO therapy for COVID-19.
    19浏览量
    原文链接